Evidence map›Paper›PMID 40227629›Full record

ArticleCancers2025

Post-Transplant Cyclophosphamide-Based Prophylaxis and Its Impact on Infectious Complications and Immune Reconstitution According to Donor Type.

Beatriz Merchán-Muñoz, María Suárez-Lledó, Luis Gerardo Rodríguez-Lobato, Tommaso Francesco Aiello, Antonio Gallardo-Pizarro, Paola Charry, Joan Cid, Miquel Lozano, Alexandra Pedraza, Alexandra Martínez-Roca and 10 more

Abstract read
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Beatriz Merchán-MuñozHematopoietic Transplantation Unit, Hematology Department, Institute of Cancer and Blood Diseases (ICAMS), Hospital Clínic Barcelona, 08036 Barcelona, Spain.
María Suárez-LledóHematopoietic Transplantation Unit, Hematology Department, Institute of Cancer and Blood Diseases (ICAMS), Hospital Clínic Barcelona, 08036 Barcelona, Spain.
Luis Gerardo Rodríguez-LobatoHematopoietic Transplantation Unit, Hematology Department, Institute of Cancer and Blood Diseases (ICAMS), Hospital Clínic Barcelona, 08036 Barcelona, Spain.ORCID 0000-0001-5694-0921
Tommaso Francesco AielloDepartment of Infectious Disease, Hospital Clínic Barcelona, 08036 Barcelona, Spain.ORCID 0000-0003-4441-6318
Antonio Gallardo-PizarroDepartment of Infectious Disease, Hospital Clínic Barcelona, 08036 Barcelona, Spain.ORCID 0000-0003-1517-4073
Paola CharryApheresis and Cellular Therapy Unit, Hemotherapy and Hemostasis Department, Institute of Cancer and Blood Diseases (ICAMS), Hospital Clínic de Barcelona, 08036 Barcelona, Spain.ORCID 0000-0002-4777-9643
Joan CidApheresis and Cellular Therapy Unit, Hemotherapy and Hemostasis Department, Institute of Cancer and Blood Diseases (ICAMS), Hospital Clínic de Barcelona, 08036 Barcelona, Spain.ORCID 0000-0001-5445-4508
Miquel LozanoApheresis and Cellular Therapy Unit, Hemotherapy and Hemostasis Department, Institute of Cancer and Blood Diseases (ICAMS), Hospital Clínic de Barcelona, 08036 Barcelona, Spain.ORCID 0000-0003-2593-833X
Alexandra PedrazaApheresis and Cellular Therapy Unit, Hemotherapy and Hemostasis Department, Institute of Cancer and Blood Diseases (ICAMS), Hospital Clínic de Barcelona, 08036 Barcelona, Spain.
Alexandra Martínez-RocaHematopoietic Transplantation Unit, Hematology Department, Institute of Cancer and Blood Diseases (ICAMS), Hospital Clínic Barcelona, 08036 Barcelona, Spain.
Ares GuardiaHematopoietic Transplantation Unit, Hematology Department, Institute of Cancer and Blood Diseases (ICAMS), Hospital Clínic Barcelona, 08036 Barcelona, Spain.
Laia GuardiaHematopoietic Transplantation Unit, Hematology Department, Institute of Cancer and Blood Diseases (ICAMS), Hospital Clínic Barcelona, 08036 Barcelona, Spain.ORCID 0009-0006-8475-0643
Cristina MorenoHematopoietic Transplantation Unit, Hematology Department, Institute of Cancer and Blood Diseases (ICAMS), Hospital Clínic Barcelona, 08036 Barcelona, Spain.
Enric CarrerasJosep Carreras Institute Against Leukemia, Campus Clinic, 08916 Badalona, Spain.
Laura RosiñolHematopoietic Transplantation Unit, Hematology Department, Institute of Cancer and Blood Diseases (ICAMS), Hospital Clínic Barcelona, 08036 Barcelona, Spain.ORCID 0000-0002-2534-9239
Carolina García-VidalDepartment of Infectious Disease, Hospital Clínic Barcelona, 08036 Barcelona, Spain.
Francesc Fernández-AvilésHematopoietic Transplantation Unit, Hematology Department, Institute of Cancer and Blood Diseases (ICAMS), Hospital Clínic Barcelona, 08036 Barcelona, Spain.ORCID 0000-0002-3733-590X
Carmen MartínezHematopoietic Transplantation Unit, Hematology Department, Institute of Cancer and Blood Diseases (ICAMS), Hospital Clínic Barcelona, 08036 Barcelona, Spain.ORCID 0000-0002-8401-7306
Montserrat RoviraHematopoietic Transplantation Unit, Hematology Department, Institute of Cancer and Blood Diseases (ICAMS), Hospital Clínic Barcelona, 08036 Barcelona, Spain.
María Queralt SalasHematopoietic Transplantation Unit, Hematology Department, Institute of Cancer and Blood Diseases (ICAMS), Hospital Clínic Barcelona, 08036 Barcelona, Spain.ORCID 0000-0003-4567-3682

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

allo-HCTimmune reconstitutioninfection densityinfectious complicationsPTCY-based prophylaxis

Identifiers

PMID40227629
PMCPMC11987969

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.